Detection of Human Papillomavirus in Clinical Samples

Otolaryngologic Clinics of North America

Volumn 45, Issue 4, 2012, Pages 765-777

  Westra, William H ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Hybrid capture 2; In situ hybridization; Oropharyngeal carcinoma; P16 immunohistochemistry; Squamous cell carcinoma of the head and neck

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; PROTEIN E6; PROTEIN E7; PROTEIN P16; VIRUS ANTIBODY; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

CLINICAL LABORATORY; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DNA SEQUENCE; GOLD STANDARD; HEAD AND NECK CARCINOMA; HISTOLOGY; HUMAN; HYBRID CAPTURE 2 ASSAY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; NONHUMAN; ONCOLOGY; OROPHARYNX CARCINOMA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SQUAMOUS CELL CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS LOAD; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION;

EID: 84863878738     PISSN: 00306665     EISSN: 15578259     Source Type: Journal    
DOI: 10.1016/j.otc.2012.04.001     Document Type: Review

References (40)

1. Gillison M.L. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004, 31:744-754.
2. Gillison M.L., Koch W.M., Capone R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92:709-720.
3. D'Souza G., Kreimer A.R., Viscidi R., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007, 356:1944-1956.
4. Gillison M.L., D'Souza G., Westra W., et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008, 100:407-420.
5. Begum S., Cao D., Gillison M., et al. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005, 11:5694-5699.
6. El-Mofty S.K., Zhang M.Q., Davila R.M. Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma. Head Neck Pathol 2008, 2:163-168.
7. Westra W.H. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 2009, 3:78-81.
8. Ang K.K., Harris J., Wheeler R., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010, 363:24-35.
9. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008, 100:261-269.
10. Weinberger P.M., Yu Z., Haffty B.G., et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006, 24:736-747.
11. American Joint Committee on Cancer AJCC cancer staging manual 2011, Springer, New York.
12. Wenig B.M., Barnes L., Carlson D.L., et al. Protocol for the examination of specimens from patients with carcinomas of the pharynx 2011, College of American Pathologists, Northfield (MN).
13. Singhi A.D., Westra W.H. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010, 116:2166-2173.
14. Begum S., Gillison M.L., Ansari-Lari M.A., et al. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003, 9:6469-6475.
15. Begum S., Gillison M.L., Nicol T.L., et al. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 2007, 13:1186-1191.
16. Weichert W., Schewe C., Denkert C., et al. Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung. Am J Surg Pathol 2009, 33:513-520.
17. Cao D., Begum S., Ali S.Z., et al. Expression of p16 in benign and malignant cystic squamous lesions of the neck. Hum Pathol 2010, 41:535-539.
18. Zhao M., Rosenbaum E., Carvalho A.L., et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer 2005, 117:605-610.
19. Worden F.P., Kumar B., Lee J.S., et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol 2008, 26:3138-3146.
20. Agrawal Y., Koch W.M., Xiao W., et al. Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. Clin Cancer Res 2008, 14:7143-7150.
21. Chuang A.Y., Chuang T.C., Chang S., et al. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol 2008, 44:915-919.
22. Paz I.B., Cook N., Odom-Maryon T., et al. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997, 79:595-604.
23. Singhi A.D., Califano J., Westra W.H. High-risk human papillomavirus in nasopharyngeal carcinoma. Head Neck 2011, 34(2):213-218.
24. Pai S.I., Westra W.H. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol 2009, 4:49-70.
25. El-Mofty S.K., Lu D.W. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2005, 29:1367-1372.
26. Kim W.Y., Sharpless N.E. The regulation of INK4/ARF in cancer and aging. Cell 2006, 127:265-275.
27. Takeuchi S., Takahashi A., Motoi N., et al. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo. Cancer Res 2010, 70:9381-9390.
28. Strati K., Lambert P.F. Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer. Cancer Res 2007, 67:11585-11593.
29. Smeets S.J., Hesselink A.T., Speel E.J., et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007, 121:2465-2472.
30. Robinson M., Sloan P., Shaw R. Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral Oncol 2010, 46:492-496.
31. Hoffmann M., Ihloff A.S., Gorogh T., et al. p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int J Cancer 2010, 127:1595-1602.
32. Klussmann J.P., Gultekin E., Weissenborn S.J., et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003, 162:747-753.
33. Shapiro G.I., Park J.E., Edwards C.D., et al. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res 1995, 55:6200-6209.
34. Ukpo O.C., Flanagan J.J., Ma X.J., et al. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol 2011, 35:1343-1350.
35. Jannapureddy S., Cohen C., Lau S., et al. Assessing for primary oropharyngeal or nasopharyngeal squamous cell carcinoma from fine needle aspiration of cervical lymph node metastases. Diagn Cytopathol 2010, 38:795-800.
36. Umudum H., Rezanko T., Dag F., et al. Human papillomavirus genome detection by in situ hybridization in fine-needle aspirates of metastatic lesions from head and neck squamous cell carcinomas. Cancer 2005, 105:171-177.
37. Zhang M.Q., El-Mofty S.K., Davila R.M. Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary. Cancer 2008, 114:118-123.
38. Carozzi F.M., Del Mistro A., Confortini M., et al. Reproducibility of HPV DNA testing by hybrid capture 2 in a screening setting. Am J Clin Pathol 2005, 124:716-721.
39. IARC Working Group on the Evaluation of Cancer Preventive Strategies Cervix cancer screening 2005, IARC Press, Lyon (France).
40. Bishop J.A., Maleki Z., Valsamakis A., et al. Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status. Cancer Cytopathol 2012, 120(1):18-25.